mHealth for Sexually Transmitted Infections
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether text messages can help people adhere to their treatment for sexually transmitted infections (STIs) more effectively than usual care, which excludes these messages. It focuses on common STIs like gonorrhea and chlamydia. Participants are divided into two groups: one receives treatment-related text messages (mHealth intervention), while the other receives usual care without messages. Suitable candidates for this trial have visited the Emergency Department, tested positive for specific STIs, and have a phone capable of receiving texts. As an unphased trial, this study allows participants to contribute to innovative research that could enhance STI treatment adherence for many.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this mHealth intervention is safe for STI treatment adherence?
Research has shown that mobile health (mHealth) tools, such as treatment-related text messages, are generally safe and easy to use. Studies have found that these tools can enhance understanding of sexually transmitted infections (STIs) and facilitate access to testing services. No strong evidence indicates serious side effects or problems from using mHealth tools.
In large studies involving over 13,000 participants, digital health methods have successfully promoted safer sexual practices and improved sexual health. This suggests that using text messages in health programs does not pose significant risks. Given the similarity of the mHealth tool in this trial to those studied, it is expected to be equally safe.12345Why are researchers excited about this trial?
Researchers are excited about the mHealth intervention for sexually transmitted infections because it uses technology in a new way to support adolescent health. Unlike traditional treatments that often focus solely on medication or in-person consultations, this approach delivers treatment-related text messages. This digital method aims to improve adherence to care and provide timely information, making it more accessible and engaging for young people who are accustomed to using mobile devices. By integrating health management into everyday technology, it has the potential to enhance the effectiveness of existing care practices.
What evidence suggests that this mHealth intervention is effective for improving STI treatment adherence?
This trial will compare the effectiveness of an mHealth intervention with usual care. Studies have shown that mobile health (mHealth) tools can effectively improve the prevention of sexually transmitted infections (STIs) and encourage healthier behaviors. Research indicates that these tools can increase testing for HIV and other STIs and promote condom use. For example, one study found that a mobile-based educational program significantly improved health habits. Another study suggested that digital health tools might help prevent STIs and substance use problems. Overall, these findings suggest that mHealth tools could support adherence to STI treatments by providing accessible information and reminders through text messages.14678
Who Is on the Research Team?
Monika Goyal, MD
Principal Investigator
Children's National Research Institute
Are You a Good Fit for This Trial?
This trial is for adolescent patients who have tested positive for gonorrhea, chlamydia, or pelvic inflammatory disease in the Emergency Department and are prescribed outpatient antibiotics.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive STI treatment with adherence monitored through text messages or usual care
Follow-up
Participants are monitored for STI treatment adherence and receipt after treatment
What Are the Treatments Tested in This Trial?
Interventions
- mHealth Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Children's National Research Institute
Lead Sponsor